Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
209.88
+3.64 (1.76%)
At close: Jun 26, 2026, 4:00 PM EDT
207.69
-2.19 (-1.04%)
After-hours: Jun 26, 2026, 7:15 PM EDT
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Quest Diagnostics stock have an average target of 223.5, with a low estimate of 210 and a high estimate of 235. The average target predicts an increase of 6.49% from the current stock price of 209.88.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Quest Diagnostics stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 8 | 8 | 9 | 9 | 9 | 9 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 15, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $226 | Buy | Maintains | $226 | +7.68% | Jun 10, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $220 | Hold | Maintains | $220 | +4.82% | May 7, 2026 |
| UBS | UBS | Hold Maintains $210 → $220 | Hold | Maintains | $210 → $220 | +4.82% | Apr 22, 2026 |
| Truist Financial | Truist Financial | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Apr 22, 2026 |
Financial Forecast
Revenue This Year
11.85B
from 11.04B
Increased by 7.42%
Revenue Next Year
12.38B
from 11.85B
Increased by 4.42%
EPS This Year
10.77
from 9.85
Increased by 9.33%
EPS Next Year
11.67
from 10.77
Increased by 8.37%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.9B | 12.6B | |
| Avg | 11.9B | 12.4B | |
| Low | 11.8B | 12.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.0% | 6.4% | |
| Avg | 7.4% | 4.4% | |
| Low | 6.8% | 3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.11 | 12.30 | |
| Avg | 10.77 | 11.67 | |
| Low | 10.55 | 11.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.8% | 14.2% | |
| Avg | 9.3% | 8.4% | |
| Low | 7.1% | 5.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.